Translocation t(4;14) may activate the FGFR3 oncogene by gene fusion or rearrangement, and some preclinical data show that cell growth arrest and apoptosis in myeloma cell lines bearing this fusion/rearrangement can be achieved by FGFR3 inhibition [24]. This evidence concerns the gene FGFR3 and plasma cell myeloma.